- News
News
Glasgow-based health tech company Phlo has been named one of the UK's fastest growing tech businesses in the 2026 Deloitte UK Technology Fast 50, achieving 3.,846% growth over three years.
More
- News
News
The Glasgow-headquartered biotechnology company will work with the English Premier League football club on a 12-week trial that researchers believe is the first high-frequency plasma proteomics study of its kind in professional sport.
More
- News
News
Researchers from the James Watt School of Engineering are playing a key role in a new healthcare research hub which aims to develop innovative technologies to help identify and monitor people with flu and other acute respiratory infections.
More
- News
News
Two University of Strathclyde projects have secured £371,678 in Scottish Government Proof of Concept funding to advance innovations in sustainable manufacturing and healthcare.
More
- News
News
Researchers at the Universities of Strathclyde have proposed a pioneering method to detect hypothetical ‘mirror life’ using circularly polarised light. The approach could provide an early detection tool against potential future biosecurity threats posed by mirror organisms, which scientists warn could interact unpredictably with existing biological systems.
More
- News
News
Researchers at UWS have proposed using personalised digital twins to better understand how individuals age. By combining data from blood tests, wearables, fitness, sleep and lifestyle, the virtual model could track changes over time and help distinguish short-term health improvements from interventions that genuinely influence long-term healthy ageing.
More
- News
News
University of Glasgow spinout Entourage AI has partnered with athlete intelligence platform Xalo Labs to combine blood-based biomarker monitoring with real-time performance data. The collaboration aims to give professional sports teams earlier insights into injury risk, fatigue and recovery, helping medical and performance staff make more informed decisions.
More
- News
News
A pioneering CAR-T therapy at Glasgow’s Queen Elizabeth University Hospital has put a myeloma patient into remission after conventional treatments stopped working. Now NHS Greater Glasgow and Clyde clinicians are exploring whether the personalised treatment, which reprogrammes patients’ own immune cells, could also help people living with severe autoimmune diseases.
More